Enforcement discretion for manufacturing to increase infant formula supplies in the US has been extended to early January as the Food and Drug Administration provides guidance for firms currently using temporary clearances to market their products to work toward becoming fully compliant.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?